Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 175Leukemia 147Myelodysplastic Syndromes 138Precursor Cell Lymphoblastic Leukemia-Lymphoma 112Lymphoma 99Lymphoma, Non-Hodgkin 86Multiple Myeloma 81Hodgkin Disease 74Leukemia, Lymphocytic, Chronic, B-Cell 69Congenital Abnormalities 62Leukemia, Myeloid, Chronic-Phase 60Myeloproliferative Disorders 57Lymphoma, Large B-Cell, Diffuse 56Neoplasms, Plasma Cell 53Leukemia, Myelomonocytic, Chronic 53Leukemia, Myeloid, Accelerated Phase 52Lymphoma, Follicular 51Lymphoma, Mantle-Cell 47Burkitt Lymphoma 46Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Lymphoma, B-Cell, Marginal Zone 44Lymphoma, Large-Cell, Immunoblastic 43Blast Crisis 43Anemia, Refractory, with Excess of Blasts 43Primary Myelofibrosis 40Recurrence 36Hematologic Neoplasms 35Graft vs Host Disease 35Myelodysplastic-Myeloproliferative Diseases 34Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 32

Interventions

Metformin 2thymoglobulin 1fludarabine phosphate 1fludarabine 1bicalutamide 1Saline Solution 1Nutrition Assessment 1Heparin 1Exercise 1Clofarabine 1Caloric Restriction 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Metabolic Diseases × Busulfan × Clear all
NCT01596699 2020-02-26

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

University of California, San Francisco

Phase 2 Terminated
16 enrolled 11 charts

Bone Marrow Failure Disorders, Metabolic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡